EX-99.1(B)3 6 dex991b3.htm BALANCE SHEETS Balance Sheets
Exhibit 99.1(b)3
 
CONSOLIDATED BALANCE SHEETS
NDCHealth Corporation and Subsidiaries
 
(In thousands, except share data)

    
November 29, 2002

    
May 31, 2003

 
ASSETS
                 
Current assets:
                 
Cash and cash equivalents
  
$
97,388
 
  
$
13,447
 
Accounts receivable
  
 
80,738
 
  
 
76,161
 
Allowance for doubtful accounts
  
 
(7,939
)
  
 
(5,710
)
    


  


Accounts receivable, net
  
 
72,799
 
  
 
70,451
 
    


  


Income tax receivable
  
 
174
 
  
 
2,229
 
Deferred income taxes
  
 
8,539
 
  
 
19,987
 
Prepaid expenses and other current assets
  
 
26,090
 
  
 
23,258
 
    


  


Total current assets
  
 
204,990
 
  
 
129,372
 
    


  


Restricted cash
  
 
145,875
 
  
 
—  
 
Property and equipment, net
  
 
111,400
 
  
 
101,566
 
Intangible assets, net
  
 
379,684
 
  
 
377,322
 
Deferred income taxes
  
 
19,564
 
  
 
21,403
 
Investments
  
 
13,748
 
  
 
13,497
 
Other
  
 
27,796
 
  
 
15,024
 
    


  


Total Assets
  
$
903,057
 
  
$
658,184
 
    


  


LIABILITIES AND STOCKHOLDERS’ EQUITY
                 
Current liabilities:
                 
Line of credit
  
$
—  
 
  
$
91,000
 
Short-term borrowings
  
 
—  
 
  
 
11,906
 
Current portion of long-term debt
  
 
8,439
 
  
 
963
 
Obligations under capital leases
  
 
1,499
 
  
 
1,296
 
Accounts payable and accrued liabilities
  
 
68,130
 
  
 
76,047
 
Deferred income
  
 
20,661
 
  
 
21,089
 
    


  


Total current liabilities
  
 
98,729
 
  
 
202,301
 
    


  


Long-term debt
  
 
468,094
 
  
 
151,910
 
Obligations under capital leases
  
 
1,144
 
  
 
1,779
 
Deferred income
  
 
8,460
 
  
 
—  
 
Other long-term liabilities
  
 
22,252
 
  
 
22,592
 
    


  


Total liabilities
  
 
598,679
 
  
 
378,582
 
    


  


Commitments and contingencies
                 
Minority interest in equity of subsidiaries
  
 
20,790
 
  
 
21,856
 
Stockholders’ equity:
                 
Preferred stock, par value $1.00 per share; 1,000,000 shares authorized, none issued
  
 
—  
 
  
 
—  
 
Common stock, par value $.125 per share; 200,000,000 shares authorized; 34,763,382 and 34,643,922 shares issued, respectively.
  
 
4,345
 
  
 
4,330
 
Capital in excess of par value
  
 
213,559
 
  
 
212,026
 
Retained earnings
  
 
75,258
 
  
 
54,194
 
Deferred compensation and other
  
 
(5,826
)
  
 
(6,743
)
Other comprehensive income
  
 
(3,748
)
  
 
(6,061
)
    


  


Total stockholders’ equity
  
 
283,588
 
  
 
257,746
 
    


  


Total Liabilities and Stockholders’ Equity
  
$
903,057
 
  
$
658,184